ES2162551B1 - Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. - Google Patents

Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.

Info

Publication number
ES2162551B1
ES2162551B1 ES9900741A ES9900741A ES2162551B1 ES 2162551 B1 ES2162551 B1 ES 2162551B1 ES 9900741 A ES9900741 A ES 9900741A ES 9900741 A ES9900741 A ES 9900741A ES 2162551 B1 ES2162551 B1 ES 2162551B1
Authority
ES
Spain
Prior art keywords
procedure
tumor cells
defective adenovirus
selective replication
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9900741A
Other languages
English (en)
Other versions
ES2162551A1 (es
Inventor
Y Cajal Agueras Santiago Ramon
Marti Covadonga Alonso
Duque Pilar Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Autonoma de Madrid
Original Assignee
Universidad Autonoma de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autonoma de Madrid filed Critical Universidad Autonoma de Madrid
Priority to ES9900741A priority Critical patent/ES2162551B1/es
Publication of ES2162551A1 publication Critical patent/ES2162551A1/es
Application granted granted Critical
Publication of ES2162551B1 publication Critical patent/ES2162551B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Procedimiento para la replicación selectiva de adenovirus defectivos en células tumorales, que consiste en el uso de adenovirus delecionados del gen E1B completo, tanto de la zona que codifica para la proteína de 55k y 19k, cualquiera que sea la vía de administración.
ES9900741A 1999-04-09 1999-04-09 Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. Expired - Fee Related ES2162551B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9900741A ES2162551B1 (es) 1999-04-09 1999-04-09 Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9900741A ES2162551B1 (es) 1999-04-09 1999-04-09 Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.

Publications (2)

Publication Number Publication Date
ES2162551A1 ES2162551A1 (es) 2001-12-16
ES2162551B1 true ES2162551B1 (es) 2002-07-01

Family

ID=8307984

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9900741A Expired - Fee Related ES2162551B1 (es) 1999-04-09 1999-04-09 Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.

Country Status (1)

Country Link
ES (1) ES2162551B1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US5858678A (en) * 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US6403370B1 (en) * 1997-02-10 2002-06-11 Genstar Therapeutics Corporation Oncolytic/immunogenic complementary-adenoviral vector system

Also Published As

Publication number Publication date
ES2162551A1 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
DK1082410T3 (da) Humane CD45 - og/eller fibroblast mesenchymale stamceller
TR200100056T2 (tr) Nörotrofik faktörler
ATE310829T1 (de) Zelllinien und konstrukte für die herstellung von e1-deletierten adenoviren in abwesenheit von replikationskompetentem adenovirus
TR200102308T2 (tr) Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı
NO950939L (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
ATE540686T1 (de) Adenovirus mit erhöhter infektiosität und konditionaler replikationsfähigkeit und deren verwendungen
ATE286139T1 (de) Replikationskompetente anti-tumor vektoren
DE69820908D1 (de) N-benzyl-3-indenylaceamidderivative zur behandlung von neoplasia
NO20011132D0 (no) FremgangsmÕte til Õ innføre apoptosis i kreftceller
IT1317835B1 (it) Citochine modificate per uso nella terapia del cancro.
UY27192A1 (es) Inhibidores de peptido-deformilasa
DE69926251D1 (de) Verfahren zum vernichten von tumoren und tumor-assoziierten endothelialzellen mit adenoviralen mutanten
ES2162551B1 (es) Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.
PL376573A1 (pl) Nowe adenowirusy, kodujące je kwasy nukleinowe i ich zastosowanie
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
ES2183752T1 (es) Vectores adenovirales recombinantes y su utilizacion en el tratamiento de distintos tipos de la fibrosis hepatica, renal y pulmonar y cicatrices hipertroficas.
DE69828791D1 (de) Das antigen ha-1
DK1224310T3 (da) Fremstilling af rekombinante adenovira og adenovirale banker
NO986035D0 (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i
TR199802387T2 (xx) Do�um kontrol� i�in kullan�lan Zona Pellucida proteinleri.
FR2811682A3 (fr) Utilisation du dextran marque pour la detection de la permeabilisation de la membrane plasmique ou la mort cellulaire
ITIM980003A0 (it) Sistema per la creazione di terreni galleggianti, mobili e coltivabili
EP0843006A3 (en) Recombinant PSA expression vectors and assays using the same

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011216

Kind code of ref document: A1

Effective date: 20011216

FD2A Announcement of lapse in spain

Effective date: 20190726